Adenocarcinoma of the Pancreas Recruiting Phase 2 Trials for Olaparib (DB09074)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02498613A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsTreatment
NCT03851614Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid TumorsTreatment